Abstract
Carcinogenesis induced by environmental metal exposure is a major public health concern. The exact mechanisms underlying metal carcinogenesis remain elusive. In the past few decades, the relationship between metal-induced generation of reactive oxygen species (ROS) and the mechanism of metal carcinogenesis has been established. The carcinogenic process is a very complex one. In the early stage of metal carcinogenesis or cell transformation, high levels of ROS are oncogenic by causing DNA damage, genetic instability, epigenetic alteration, and metabolic reprogramming, leading to malignant transformation. In the second stage of metal carcinogenesis or the cancer development of metal-transformed cells, low levels of ROS are carcinogenic by promoting apoptosis resistance. The metal-transformed cells have the property of autophagy deficiency, resulting in accumulation of p62 and constitutive activation of NF-E2-related factor 2 (Nrf2) and leading to higher levels of antioxidants, decreased levels of ROS, apoptosis resistance, inflammation, and angiogenesis. This review summarizes the most recent development in the field of metal carcinogenesis with emphasis on the difference in cellular events between early (cell transformation) and late (after cell transformation) stages of metal carcinogenesis.
Original language | English |
---|---|
Pages (from-to) | 178-186 |
Number of pages | 9 |
Journal | Current Pharmacology Reports |
Volume | 2 |
Issue number | 4 |
DOIs | |
State | Published - Aug 1 2016 |
Bibliographical note
Publisher Copyright:© 2016, Springer International Publishing AG.
Keywords
- Carcinogenesis
- Metal
- Nrf2
- Reactive oxygen species (ROS)
- Tumorigenesis
ASJC Scopus subject areas
- Biochemistry
- Genetics
- Pharmacology
- Drug Discovery